Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Clinical Study of Autologous Hematopoietic Stem Cell Transplantation and Chemotherapy as First-Line Consolidation Therapy After Obtaining a Complete Therapeutic Response in T-Cell Lymphoma

NCT06149390 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT06149390
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06149390 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Clinical Study of Autologous Hematopoietic Stem Cell Transplantation and Chemotherapy as First-Line Consolidation Therapy After Obtaining a Complete Therapeutic Response in T-Cell Lymphoma
Lead sponsor
Huazhong University of Science and Technology
Phase
Observational
Overall status
Completed
Start date
January 1, 2014
Completion date
July 1, 2023
Enrollment
347 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

t-cell lymphoma adults